Ir para o conteúdo

Fluorochem Ltd

@fluorochemltd.bsky.social did:plc:ukbevyhvnhmnfvy2uqmfbxfo

Fluorochem is a leading supplier in the chemical industry, with nearly 60 years of experience supporting scientists in chemistry, pharmaceuticals and medicinal chemistry, and advanced molecular research.

No Bluesky desde

Seguidores
32
Seguindo
20
Posts
70
Dias nos rankings
0

Resumo

Fluorochem Ltd (@fluorochemltd.bsky.social) é um usuário do Bluesky desde 17 fevereiro 2025. Tem 32 seguidores, segue 20 contas e publicou 70 posts.

Aparições nos rankings

Os melhores dias em que posts desta conta entraram na lista diária do Debya.

Esta conta ainda não apareceu em um ranking diário.

Posts curtidos recentemente

Curtidas públicas da rede Bluesky.

  • The Francis Crick Institute@crick.ac.uk

    We're now recruiting early career group leaders at the Crick to lead ambitious research programmes and explore bold scientific questions. Hear our Director, Edith Heard, explain why the Crick is a unique place for curiosity-driven research. Apply now ➡️ www.crick.ac.uk/careers-stud...

    Ver post
  • Dr Kerry Elgie@kerryasynt.bsky.social

    Happy 1st October! 🍁 The brilliant reds, oranges & yellows of autumn leaves aren’t just a seasonal show, they’re the result of clever chemistry. A perfect reminder that chemistry always leaves us impressed. 🍂 Many thanks to @compoundchem.com for the fabulous graphic. #ColourChemistry

    Ver post
  • C&EN (Chemical & Engineering News)@cenmag.bsky.social

    ICYMI: Researchers at the University of Edinburgh have engineered a strain of Escherichia coli that relies on small molecules from waste polyethylene terephthalate (PET) plastic bottles to survive. cen.acs.org/biological-c... #chemsky 🧪

    Ver post
  • Chemical Science@chemicalscience.rsc.org

    New in Chemical Science! "Carboxylato-prism[6]arene as a supramolecular catalyst in water: exploiting its deep hydrophobic cavity for green oxidation of aromatic amines" by Antonio Rescifina, @carminegaeta.bsky.social, @maderosa.bsky.social and colleagues! Read for free: doi.org/10.1039/D5SC...

    Ver post
  • Malte Gersch@maltegersch.bsky.social

    Super happy to share that our work on the specific inhibition of USP30 - a clinical stage Parkinson's drug target - is now online at NSMB www.nature.com/articles/s41... Have a read if you fancy chimeric protein engineering or a framework for DUB ligandability. Huge congratulations to Nafizul & team!

    Ver post

Entre para ver mais

Contas que bloqueia

No Bluesky, bloqueios são registros públicos.

Esta conta não bloqueia ninguém.